Xenon Pharmaceuticals Inc. ($XENE)
Kelly Thomas Patrick โ Chief Financial Officer
Shares
15,000
Price
$37.32
Total Value
$559,740.00
P&L
-10.3% ($57,390.00)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Kelly Thomas Patrick |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Sep 30, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Oct 1, 2026 |
| Shares Purchased | 15,000 |
| Price per Share | $37.32 |
| Total Value | $559,740.00 |
| Shares Owned After | 15,000 |
| Derivative | No |
| Accession Number | 0001193125-26-410001 |
| Document | View SEC Filing |